Literature DB >> 18508673

Angiogenesis and inflammation in carotid atherosclerosis.

Jerzy Krupinski1, Angels Font, Ana Luque, Marta Turu, Mark Slevin.   

Abstract

Carotid atherosclerosis is a leading cause of cerebrovascular events. The control of cardiovascular risk factors, i.e. tobacco smoking, alcohol abuse, hypertension, dyslipidemia, diabetes and obesity proved to reduce number of fatal and non-fatal strokes but failed to prevent important number of them. Screening for biomarkers in individuals at high risk of symptomatic vascular disease helped to identify some of them. However, as disease is by its nature multifocal, global testing for biomarkers may have limited practical application. New imaging techniques, including direct visualization of artery metabolism, by 18-FDG-PET, has brought new tools to study local atherosclerosis progression and individual plaque metabolic activity. Advances in molecular biology helped to identify inflammatory genes and its strong link to angiogenesis. The later, is thought to play a key role in the transformation to unstable plaque. Studies of the complex role that plays angiogenesis in plaque development will help in future to design effective therapies addressed at the individual cell level. The purpose of the review is to bring new insights into complicated pathophysiology of carotid atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508673     DOI: 10.2741/3167

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  10 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

2.  Adhesion molecule CD146 and its soluble form correlate well with carotid atherosclerosis and plaque instability.

Authors:  Yi-Ning Qian; Yong-Ting Luo; Hong-Xia Duan; Li-Qun Feng; Qi Bi; Yong-Jun Wang; Xi-Yun Yan
Journal:  CNS Neurosci Ther       Date:  2014-02-24       Impact factor: 5.243

3.  MR molecular imaging of angiogenesis using targeted perfluorocarbon nanoparticles.

Authors:  S D Caruthers; P M Winter; S A Wickline; G M Lanza; J Keupp
Journal:  Medicamundi       Date:  2010

4.  Noninvasive detection of neural progenitor cells in living brains by MRI.

Authors:  Christina H Liu; Jia Q Ren; Zerong You; Jinsheng Yang; Charng-Ming Liu; Ritika Uppal; Philip K Liu
Journal:  FASEB J       Date:  2011-12-23       Impact factor: 5.191

5.  Increased serum kallistatin levels in type 1 diabetes patients with vascular complications.

Authors:  Alicia J Jenkins; Jeffrey D McBride; Andrzej S Januszewski; Connie S Karschimkus; Bin Zhang; David N O'Neal; Craig L Nelson; Jasmine S Chung; C Alex Harper; Timothy J Lyons; Jian-Xing Ma
Journal:  J Angiogenes Res       Date:  2010-09-22

6.  Anti-inflammatory potential of β-amyrin, a triterpenoid isolated from Costus igneus.

Authors:  Kripa Krishnan; Limi Elizabeth Mathew; N R Vijayalakshmi; A Helen
Journal:  Inflammopharmacology       Date:  2014-10-10       Impact factor: 4.473

7.  Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome.

Authors:  Bee K Tan; Raghu Adya; Syed Farhatullah; Jing Chen; Hendrik Lehnert; Harpal S Randeva
Journal:  Diabetes       Date:  2010-09-17       Impact factor: 9.461

8.  New Insights into the Role of Metformin Effects on Serum Omentin-1 Levels in Acute Myocardial Infarction: Cross-Sectional Study.

Authors:  Hayder M Alkuraishy; Ali I Al-Gareeb
Journal:  Emerg Med Int       Date:  2015-11-23       Impact factor: 1.112

9.  Cardiac Affection in Type 1 Diabetic Patients in Relation to Omentin.

Authors:  Soha M Abd El Dayem; Ahmed A Battah; Amal El Shehaby
Journal:  Open Access Maced J Med Sci       Date:  2015-12-13

10.  CD105 positive neovessels are prevalent in early stage carotid lesions, and correlate with the grade in more advanced carotid and coronary plaques.

Authors:  Ana Luque; Mark Slevin; Marta M Turu; Oriol Juan-Babot; Lina Badimon; Jerzy Krupinski
Journal:  J Angiogenes Res       Date:  2009-09-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.